PAQR8 promotes breast cancer recurrence and confers resistance to multiple therapies

BACKGROUND: Breast cancer mortality is principally due to recurrent disease that becomes resistant to therapy. We recently identified copy number (CN) gain of the putative membrane progesterone receptor PAQR8 as one of four focal CN alterations that preferentially occurred in recurrent metastatic tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Saisai, Paul, Matt R., Sterner, Christopher J., Belka, George K., Wang, Dezhen, Xu, Peining, Sreekumar, Amulya, Pan, Tien-chi, Pant, Dhruv K., Makhlin, Igor, DeMichele, Angela, Mesaros, Clementina, Chodosh, Lewis A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811758/
https://www.ncbi.nlm.nih.gov/pubmed/36597146
http://dx.doi.org/10.1186/s13058-022-01559-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811758/
https://www.ncbi.nlm.nih.gov/pubmed/36597146
http://dx.doi.org/10.1186/s13058-022-01559-3

Ejemplares similares